As the HRT shortage hits the NHS, Dr Peers talks about the health risks HRT can reduce for women, including cancer risks.
Find out more about NASGP clinical webinars from our news pages.
12th May 2022 by NASGP
As the HRT shortage hits the NHS, Dr Peers talks about the health risks HRT can reduce for women, including cancer risks.
Find out more about NASGP clinical webinars from our news pages.
Like Mirabegron, Vibegron is also a beta-3 adrenergic receptor agonist.
This webinar from Dr. Eloise Elphinstone provides an update on managing unscheduled bleeding in postmenopausal women on hormone replacement therapy (HRT).
This webinar from Dr. Eloise Elphinstone provides an update on menopause and hormone replacement therapy (HRT).
"LocumDeck and the NASGP have provided excellent IT and administrative support which are my key areas of need in my GP locum workstream. Invoicing and pension forms are easily managed, fees are chased on my behalf if required, and booking work is straightforward, as my professional profile and compliance information is kept on-line in one secure place."
Dr Stuart Allan, GP, Burton-in-Kendal, Cumbria